Ankit Kansagra: AJMC IVBM Event Focuses on Delivering Cellular Therapies Across Care Settings
Ankit Kansagra/ LinkedIn

Ankit Kansagra: AJMC IVBM Event Focuses on Delivering Cellular Therapies Across Care Settings

Ankit Kansagra, Associate Vice President Oncology Integration and Community Alliance at Tampa General Hospital, Adjunct Professor at UT Southwestern Medical Center, shared on LinkedIn:

“Looking forward to joining oncology colleagues and clinical leaders tonight – September 1st in Tampa for AJMC’s Institute for Value-Based Medicine event, ‘Pioneering the Next Era of Oncology Care.’

As the therapeutic landscape rapidly advances with cellular therapies and bispecific antibodies, optimizing our site-of-care delivery models is more critical than ever. During tonight’s discussion, my colleagues Javier Pinilla Rami Komrokji Megan Melody, and I will be focusing on the operational and clinical realities of bringing these transformative treatments to patients:

Site-of-Care Evolution: Navigating the shift and bridging the operational gap between inpatient management and safe, efficient outpatient administration.

Complex Toxicity Management: Establishing robust multidisciplinary protocols across care settings to identify and manage CRS, ICANS, and delayed infection risks effectively.

Care Coordination and Access: Aligning hospital teams, specialized cellular therapy units, and community oncology partners to streamline transitions and expand patient access to cutting-edge therapies.

Delivering high-value, next-generation oncology care requires continuous innovation not just in therapeutics but in how we design our clinical infrastructure and care pathways.

Join us tonight at the Grand Hyatt Tampa Bay to be part of the conversation – you can Register – link below for the IVBM Tampa Event to attend.”

Ankit Kansagra: AJMC IVBM Event Focuses on Delivering Cellular Therapies Across Care Settings

Other articles featuring Ankit Kansagra on OncoDaily.